Trytosaveabit commented on a stock · Feb 20 06:35

Update

$Matinas BioPharma(MTNB.US)$ Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
5 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3940 Views

Comment

Trytosaveabit

2503Followers

28Following

33KVisitors